Cantabio Pharmaceuticals Inc. Share Price Other OTC
Equities
CTBO
US13808X2036
Biotechnology & Medical Research
Sales 2017 | - | Sales 2018 | - | Capitalization | 2.36M 197M |
---|---|---|---|---|---|
Net income 2017 | -1M -83.38M | Net income 2018 | -2M -167M | EV / Sales 2017 | - |
Net Debt 2017 | 337K 28.11M | Net Debt 2018 | 1.1M 91.33M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-
| Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 29.99% |
Managers | Title | Age | Since |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06/12/06 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/15/22 |
Max Zhu
BRD | Director/Board Member | 42 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/15/22 |
Gergely Tóth
FOU | Founder | 51 | 06/12/06 |
Max Zhu
BRD | Director/Board Member | 42 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |